Literature DB >> 24440764

[Gastric signet ring cell adenocarcinoma: A distinct entity].

Tessa Tabouret1, Marion Dhooge2, Alexandre Rouquette3, Catherine Brezault1, Frédéric Beuvon3, Stanislas Chaussade2, Romain Coriat4.   

Abstract

Gastric signet ring cell carcinoma (GSRC) is a distinct entity. Their incidence is increasing. The pathologist plays a central role in the identification of this entity. Diagnosis is based on an adenocarcinoma containing a majority of signet ring cells (above 50 %). The prognosis of GSRC is the same as gastric adenocarcinoma while GSRC appeared more aggressive. Signet ring cells present a low sensitivity to chemotherapy. This review aimed to discuss the histological, the prognostic and the therapeutic aspect of this entity.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Year:  2014        PMID： 24440764     DOI： 10.1016/j.lpm.2013.07.024

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


  3 in total

1.  Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.

Authors:  Haithem Zaafouri; Raja Jouini; Nizar Khedhiri; Fatma Khanchel; Mona Cherif; Meryam Mesbahi; Aziz Daghmouri; Wiem Mahmoudi; Soumaya Akremi; Meriam Sabbah; Yazid Benzarti; Dhafer Hadded; Dalila Gargouri; Mourad Ben Bader; Anis Ben Maamer
Journal:  World J Surg Oncol       Date:  2022-07-20       Impact factor: 3.253

2.  Development of prognostic predictive model with neutrophil-lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma.

Authors:  Shihai Yang; Shangdong Li
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

3.  Predicting Overall Survival in Patients with Nonmetastatic Gastric Signet Ring Cell Carcinoma: A Machine Learning Approach.

Authors:  Xiaomei Li; Zhiwei Chen; Jing Lin; Shouan Wang; Conghua Song
Journal:  Comput Math Methods Med       Date:  2022-09-13       Impact factor: 2.809
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.